For example, a VEGFR-1 blocking agent (aflibercept) that traps VEGF-A and PlGF [39,40] improved overall survival compared with a placebo in patients with metastatic colorectal cancer in a clinical study [36,37,38,39]. The gene discussed is PGF; the disease is metastatic colorectal cancer.